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Summary.-A biologically active molecule with one or more aromatic rings often
retains its activity when one of these rings is replaced by an isosteric and/or iso-
electronic aromatic ring. Consideration has been given to whether this effect can
be expected to apply to aromatic organic carcinogens. The literature relevant to
this topic has been reviewed and the thiophene analogues ofthe carcinogens benzidine
and 4-aminobiphenyl have been synthesized and evaluated for potential carcinogeni-
city. The compounds prepared were 5-p-acetamidophenyl-2-thiophenamine hydro-
chloride (XIII), 5-phenyl-2-thiophenamine hydrochloride (XIV), N-(5-p-acetamido-
phenylthiophen-2-yl)acetamide (XV) and N-(5-phenylthiophen-2-yl)-acetamide
(XVI) (see Chart for structures). Each compound was evaluated in the Salmonella
reverse-mutation assay of Ames and the cell-transformation assay of Styles. The
activity profiles observed for these compounds in vitro were consistent with their
known chemistry, and indicate potential carcinogenicity. However, their overall
chemical and biological behaviour casts doubt upon whether they would be capable of
eliciting tumours in vivo. Because it is important to establish the degree of reliance
which canbe placed upon in vitro predictions ofpotential carcinogenicity generated for
structurally new compounds, one of the thiophene derivatives, N-(5-phenylthiophen-
2-yl)acetamide (XVI), is currently being evaluated for carcinogenicity in mice.
A BIOLOGICALLY active molecule which
contains one or more aromatic rings often
retains this activity when one of these
rings is replaced by an isosteric and/or iso-
electric ring (i.e. a ring with a similar
electronic and steric structure). For exam-
ple, antidepressant activity is retained in
the pyrazolo analogue (I) of the parent
benzodiazepine (II) (deWald & Butler,
1970); similarly, replacement of the pyr-
role ring of serotonin (III) with a thio-
phene ring gives the benzo[b]thiophene
analogue (IV) which shares some of the
biological properties ofthe parent molecule
(Campaigne & Bosin, 1977). It would
therefore be expected that the judicious
replacement of part of the structure of an
established animal carcinogen with an
electronically or sterically similar sub-
structure would, on occasions, yield a
structurally novel carcinogen. Such a
carcinogen, would be chemically, and
probably biologically, related to the parent
carcinogen yet the association may not
be apparent upon visual inspection of
its chemical structure. Two illustrations
of this principle are afforded by the
carcinogenic activity (Robinson & Tilak,
1947) of the thiophene analogue (V) of
the polycyclic aromatic hydrocarbon car-
cinogen 7,12-dimethylbenz[a]anthracene
(IV) and by the carcinogenicity of several
amino derivatives of dibenzothiophene,
such as 3-amino-dibenzothiophene (VII),
which could be regarded as isosteric
analogues of the carcinogen 2-amino-
anthracene (VIII) (reviewed Ashby &
Cook, 1974). In these examples, a benzene
ring of both (VI) and (VIII) has been
replaced by a thiophene ring, the change
being accompanied by a retention of
carcinogenic activity.J. ASHBY, J. A. STYLES, D. ANDERSON AND D. PATON
Evaluation of the carcinogenic signifi-
cance of aromatic ring replacements may
have a useful part to play when attempting
to screen established or new chemicals for
potential carcinogenicity. For example, if
accurate information had been available
concerning which ring changes can be
made to established aromatic carcinogens
whilst still retaining carcinogenic activity,
it is probable that the recently defined
and apparently novel class of hetero-
aromatic carcinogens andmutagens (Cohen
et al., 1975; Wang et al., 1975) of which
IX and X are representative, could have
been anticipated by virtue of their ring-
exchange relationship to the carcinogens
benzidine (XI) and4-aminobiphenyl (XII).
[For such purpose the equivalence of an
aromatic amino or acetylamino group with
an aromatic hydroxylamino or nitro group
is assumed; for example, 4-nitro-4'-amino-
biphenyl induces bladder cancer in rats,
(Laham & Sinclair, 1969) as does the
parent carcinogen 4,4'-diaminobiphenyl
(benzidene XI).]
The present paper describes the syn-
thesis and some of the in vitro biological
properties of the thiophene analogues XII
and XV of the carcinogen benzidine (XI),
and the corresponding analogues XIV
and XVI of the carcinogen 4-aminobi-
phenyl (XII). These compounds were
selected for study because there was
circumstantial evidence of possible car-
cinogenicity, namely, that the thiophene
analogue XVII of the carcinogenic nitro-
furan derivative XVIII is also carcino-
genic. Further, the des-nitro analogue of
XVII, namely, the thiophene XIX, is
non-carcinogenic (Cohen & Bryan, 1973)
which establishes the carcinogenic im-
portance ofthe nitro group and defines the
thiophene ring as being merely an effec-
tive replacement for a furan ring (i.e.
the thiophene ring has no carcinogenic
significance per se).
In this introduction, the possible equi-
valence within the structure of a car-
cinogen of a thiophene ring and either a
benzene ring or a furan ring, or of a
benzene ring and either a pyrazole,
thiadiazole or a thiazole ring has been
implied. Thus, a major reason for evalua-
ting such structural relationships is that,
in the absence of well established and
explained exceptions, it must be assumed
that there are as many possibly carcino-
genic analogues ofthe established aromatic
carcinogens as there are aromatic ring
systems nominally isosteric and isoelec-
tronic with benzene. This conclusion is
probably quite incorrect as a generaliza-
tion, and should therefore be rapidly
evaluated by testing representative ana-
logues in one or more of the available in
vitro carcinogenicity assays. With this
objective, the possible carcinogenicity of
the 4 thiophenes, XIII-XVI, has been
evaluated in 2 in vitro carcinogenicity
tests, namely the Salmonella reverse-
mutation assay of Ames and the cell-
transformation assay of Styles.
MATERIALS AND METHODS
Chemicals.-The C, H and N content of
each compound has been determined, and in
each case the results are within 0.4% of the
calculated values. In addition, the 1H NMR,
IR and mass spectra of each compound have
been determined, and are consistent with
the structures shown. No significant im-
purities in any of the test compounds were
detected by the above methods or by thin
layer chromatography (TLC). Spectroscopic
details can be provided upon request.
5-Phenyl-2-thiophenamino hydrochloride
(XVI) was prepared by treating fl-benzoyl-
propionitrile (Knott, 1947) with a mixture of
hydrogen sulphide and hydrogen choride
gases as described by Baird et al. (1976). A
solution of the crude product in methanol,
after treatment with a small quantity of
charcoal, was chilled in acetone/Drikold and
filtered. After washing with dry ether, the
colourless crystalline product had m.p.
195-197°C dec (no literature on m.p. avail-
able) (70%). This material discolours quickly
in air and light, particularly when warmed.
N-(5-phenylthiophen-2-yl)acetamide (XVI)
was prepared by treatment of the parent
amine hydrochloride in water with acetic
anhydride and sodium hydroxide (2N) at
45°C. The crude product was collected,
washed with water and recrystallized from
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ethanol, m.p. 184°C (no literature on m.p.
available) (68%).
5-p-acetamidophenyl-2-thiophenamine hydro-
chloride (XIII).-The preparation of this
compound required the synthesis of several
new intermediates. The synthetic sequence is
described below.
4-Acetylacetamilide was prepared by the
method of Yasue et al. (1961), m.p. 167-
168°C (from ethyl acetate) [Yasue et al.
report m.p. 166-167°C]. (CAUTION. The
reaction of acetanilide with aluminium
chloride requires iniitiation by gently warming
but then becomes violent.)
4-Acetamido-w-(N,N-dimethylamino)propio-
phenone was prepared from the above
material by the method of McEvoy & Allen
(1973) (88%) m.p. 202-204°C (as hydriodide)
(no literature on m.p. available).
w-(4-Acetamidobenzoyl)propionitrile.-4-
Acetamido-w-(N,N-dimethyl-amino)propio-
phenone (11.53 g) was added to a solution of
potassium cyanide (10.38 g, 2 equivs) in
water (100 bl) and the mixture heated as
rapidly as possible to the boil. After boiling
for 5 min the reaction mixture was cooled
quickly in ice and the product collected and
washed with water. M.p. 180-181°C (79.5%).
Recrystallization from methanol (charcoal)
gave the product as shining rods ot m.p.
185-186°C (no literature on m.p. available).
Reaction of the above propionitrile with a
mixture of hydrogen sulphide and hydrogen
chloride gases in ethanol, as described above
for the synthesis of XIV gave the required
product, 5-p-Acetamidophenyl-2-thiophena-
mine hydrochloride (XIII) (31%) m.p. 240-
241°C (no literature on m.p. available).
This material is sensitive to light and air.
Heating in methanol generates impurities
which can be detected by TLC, and heating
a solution of this material in higher-boiling
solvents causes decomposition, as evidenced
by a darkening of the solution.
N-(5-p-Acetamidophenylthiophen-2-yl)aceta-
mide (XV) was prepared as described for the
conversion of the thiophene XIV to the
thiophene XVI, (70%) m.p. 262-263°C (no
literature on m.p. available) (analyses as
hemihydrate).
Benzidene (XI) was obtained from BDH
Chemicals Ltd, Poole, Dorset, m.p. 128-
129°C (Merz and Strasser, 1899 report m.p.
128°C).
The Ames Test.-The materials, method,
dose levels and control chemicals used have
been described previously (Purchase et al.,
1977; Ashby et al., 1977). Bacteria (Strains
TA 1535, TA 1538, TA 98 and TA 100) were
obtained from Professor B. N. Ames, Berkeley
Cal., USA. In addition to the normal chemical
controls, benzidine (XI) was used as the rele-
vant chemical-class positive control (Ashby
& Purchase, 1977). Positive-control chemi-
cals gave an increase of 10-20-fold in each
experiment. The 4 thiophene derivatives
XIII-XVI, together with benzidine (XI),
were tested in both the presence and absence
of Aroclor 1254-induced rat liver S-9 mix
(Ames et al., 1975). Dimethylsulphoxide
(DMSO, BDH Chemicals Ltd, Poole, Dorset)
was used as both solvent and negative
control.
Thecell-transformationassay.-Themethod-
ology used was exactly as described in
previous papers (Styles, 1977; Ashby et al.,
1977; 1978a, b). The cells used were BHK
21/C13 which had a spontaneous transforma-
tion frequency of 50 per 106 cells. All experi-
ments were repeated, the data shown repre-
senting the average of 2 experiments.
RESULTS
Ames assay
The 4 thiophene derivatives, XIII-
XVI, were tested as a group in the
4 Salmonella strains on 3 separate occa-
sions. Benzidine (XI) the chemical-class
positive control was positive on each
occasion. During the course of this testing
programme, each of the thiophenes pro-
duced a positive response on at least one
occasion, in either strain TA 1538 or
TA 98. These responses were not re-
producible, and sometimes were produced
in the absence of S-9 mix. A typical posi-
tive response given by benzidine is
shown in Fig. 1(a), whilst Fig. 1(b) shows a
positive response given byN-(5-p-acetami-
dophenylthiophen-2-yl) acetamide (XV).
Cell transformation assay
The 4 thiophene derivatives, XIII-
XVI, together with benzidine (XI), were
tested as a group in the presence of S-9
mix on 2 separate occasions. On each
occasion, the acetyl derivatives XV and
XVI, together with benzidine (XI), gave
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benzene ring in biologically active mole-
cules has been reviewed (Campaigne &
Bosin, 1977). Although the steric, elec-
tronic and metabolic changes which ac-
company such ring replacements are
often marked, it is usually observed that
at least some of the biological charac-
teristics of the parent molecule are
retained. It was therefore anticipated that
activity indicative of potential carcino-
genicity would be encountered with the
thiophenes XIII-XVI in the 2 in vitro
assays used in this study. The activity
profile is consistent with the chemical
stability and reactivity of these com-
0 4 20 100 500 2500 pounds, and makes possible a fairly firm
Concentrationpglplate prediction of their likely carcinogenic
properties in vrio.
The 2 amine hydrochloride derivatives,
XIII and XIV, were unstable to heat and
light. Thus although they were each
sufficiently stable to enable them to be
synthesized and tested, each had to be
crystallized with care and stored at 0°C in
the dark, in order to retain their chemical
integrity (as monitored by TLC and m.p.).
In contrast, the two acetylated derivatives,
XV and XVI, were stable by the above
criteria. This change in stability is con-
sistent with the known instability of
aminothiophenes, an effect probably de-
pendent upon oxidative attack on the
thiophene ring, which is enhanced by
0 4 20 100 500 2500 the electron-donating amino substituent.
Concentration pg/plate It is also consistent with the relative
I1.-Response given by benzidine (XI) stability of thiophenes containing a neu-
) and N-(5-p-acetamidophenylthiophen- tral substituent, such as an acetamido
-yl)acetamide (XV) (b) in the Ames assay group, or an electron-withdrawing sub-
train TA 1538, tested in the presence of stituent, such as a nitro or carboxyethyl
-roclor 1254-induced rat liver S-9 mix).
group (reviewed by Guilard et al., 1975).
sitive response (Fig. 2(a), (b) and (c) The in vitro activity pattern observed
,ctively) whilst both of the amine for the 4 thiophenes may reflect the above
ochlorides, XIII and XIV, gave a stability considerations. In the cell-trans-
tive response (Fig. 2(d) and (e) respec- formation assay the 2 acetylated deriva-
y). Both the acetyl derivatives tives, XV and XVI, each showed a
3ssed greater cytotoxicity than the toxicity curve similar to that ofbenzidine,
sponding amine hydrochlorides. and they each transformed the BHK
cells (Fig. 2(a), (b) and (c) respectively).
DISCUSSION From this it could be inferred that meta-
e extent to which a thiophene ring bolic oxidative attack on the amino
simulate either a pyrrole ring or a substituents of the thiophenes XV and
(a
2
(s
A
a po,
respe
hydr
nega
tivel
pOsse
corre
Th
can
r24CARCINOGENIC ASSAY OF BENZIDINE ANALOGUES
lOC
%survivors 5(
1,101
70C
transformarTts
per 1i6
survivors
30a
11
I - -~~~~~~~~~~~~~~~~~~~~
O
It O
0 0.025 0.25 2.5 25 250
Concentration pgq/ml
% survivors
transformants
per 106
survivors
100
% siurvivors 50
0
1,100
(a)
transformants
per 106
survivors
900
700
500
300
100
0 0.025 0.25 2.5 25 250
Concentration pq/mI
(c)
Concentration pi/lI
100
%survivors 50
0
1,100
900
700
500
300
100
I
(Xlilll
II
0
0
% survivors
100
50
0
).100
900
(d) 700
transformants 500
perlO6
survivors
300
100
0 0.025 0.25 2.5 25 250 0 0.025 0.25 2.5 25
Concerrtrrdlon / ni Concentration pg lnt
FIG. 2.-Response given by N-(5-p-acetamidophenylthiophen-2-yl)acetamide (XV) (a) N-(5-phenyl-
thiophen-2-yl)acetamide (XV) (XVI) (b), benzidine (XI) (c), 5-p-acetamidophenyl-2-thiophena-
mine hydrochloride (XIII) (d) and 5-phenyl-2-thiophenamine hydrochloride (XIV) (e) in the
cell-transformation assay of Styles.
525
(b)
transforrnants
per 1o6
survivors
(e)
250
10-011-
lxvil
I
500
ICARCINOGENIC ASSAY OF BENZIDINE ANALOGUES
100
50 _ _ ---
0
1,100
900IVkIH
700 fxvi
500
300
100
0 0.025 0.25 2.5 25 250
Concentration pg/mI
% suirvivors
(a)
transformants
per 106
survivors
100
50
'oo 1,00
900
700
500
300
100
lX
,___ _ __ _ _ / _ _ _ __._ _ __~~~~~~~~
0 0.025 0.25 2.5 25 250
Concentration pg/mI
100
50-
0
1,100
700
700 ixii
500
300
100
0 0.025 0.25 2.5 25 250
Concentration pq/
100
% survivors 50
0
1,100
900
(d) 700
transformants
per 106 500
survivors
300
Ion
-~~~~~~~~~~~~~~~~~~~~~~~~ F * _~~~~~~~~~~~~~~~~~~~
_ _ _ _ _ _ _ _ _ >~~~~
I
I
' |||.HCI |~~~~~~~~~~~~~~~~~~~~~~~~~~
= *s W-_
-
(x,V)
II
0 0.025 0.25 2.5 25 250 0 0.025 0.25 2.5 25 250
Concentratlon pq/nI Concentration pg/mI
FIG. 2.-Response given by N-(5-p-acetamidophenylthiophen-2-yl)acetamide (XV) (a) N-(5-phenyl-
thiophen-2-yl)acetamide (XV) (XVI) (b), benzidine (XI) (c), 5-p-acetamidophenyl-2-thiophena-
mine hydrochloride (XIII) (d) and 5-phenyl-2-thiophenamine hydrochloride (XIV) (e) in the
cell-transformation assay of Styles.
%survivors
transformants
per lo6
survivors
525
(b)
% survivors
transformants
per 106
survivors
(c)
100
% survivors 50
0
1,100I
900
700
transfornants
per 106 500
survivors
300
100
NHA * _ * 4
ixiiiiI
i
I ('
lwI 0 0 -.0- 0
1 3
e)CARCINOGENIC ASSAY OF BENZIDINE ANALOGUES
H2N - NH2
(XI)
NHAc Hs NH2HC
(XlIl)
NHAc /\
NH AS NHAc
(XV)
(XVII) (XVIII)
NH2
(Xll)
(XI2V HCI
(XIV)
NHAc
(XVI)
N(CnH2CH2QH)
S N
(XIX)
cases, initial oxidation of the substituent
N atom may have been accompanied by
direct or trans-oxidation (N -+ S) of the
S atom, which would probably lead to
rupture of the thiophene ring and de-
activation of the molecule. The response
given by all 4 thiophenes in the Ames
assay was erratic and predominantly
negative (Fig. l(b) shows an example of a
typical positive response). Whilst it is not
generally defensible to consider unre-
producible data, the total context in
which these were generated makes them
worthy of mention, and they are probably
significant.
The above in vitro results indicate that
these 4 thiophene derivatives, and in
36
particular the acetylated derivatives XV
and XVI, have carcinogenic potential.
However, the overall in vitro response
observed, together with the chemical and
anticipated metabolic considerations out-
lined above, raise serious doubts about
whether these compounds would be suf-
ficiently stable in vivo to elicit a carcino-
genic response. For example, oxidative
ring-opening early in their effective in
vivo lifetime might render such com-
pounds inactive, despite their established
potential to cause tumours.
The advantage of conducting a parallel
cell-toxicity assay with an in vitro car-
cinogenicity assay is well illustrated by
the above transformation assays. The
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transition from inactivity to activity as
cell-transforming agents brought about
by acetylation of the amino group of the
thiophenes XIII and XIV may reflect a
change in overall metabolism, resulting
in a change in their respective toxicity
curves. A similar critical change in test
response following changes made to the
S-9 mix has been observed with a series of
potential carcinogens related to hexa-
methylphosphoramide (Ashby et al.,
1978b). Both examples show the import-
ance of overall in vitro metabolism in
determining the test response given by a
compound. These 2 separate examples are
probably related by the fact that both
chemical and enzymic factors caninfluence
the critical concentration ofDNA-reactive
species required to produce a positive test
response.
In order to assess the in vivo significance
of this particular series of in vitro pre-
dictions, 2-acetamido-5-phenylthiophene
(XVI) is currently being assayed for
carcinogenic properties in mice. 4-Amino-
biphenyl (XII) is being used as the positive
control and the compounds are being
administered in the diet. Pending the
result ofthat studythere remains sufficient
uncertainty about the effects that these
thiophene derivatives may elicit in vivo
to ensure that, at present, isosteres of
established aromatic carcinogens which
give a positive response in in vitro assays
should be regarded as possible rather than
probable carcinogens.
The study in vitro of isosteres of estab-
lished carcinogens may enable general
principles to be explored, as well as
gaining compound-specific data. For ex-
ample, it is clear that if a structural
feature which is critical in the metabolic
activation of a carcinogen is lost, carcino-
genic activity w%ill also be lost. Therefore,
the carcinogenicity of the thiophene
isostere (V) showed that the K-region
benzene ring, and the derived K-region
epoxide, are non-critical molecular fea-
tures in the metabolic carcinogenic activa-
tion of polycyclic aromatic hydrocarbons
such as benz[a]pyrene (VI) (Robinson &
Tilak, 1947). However, for the next 20
years the K-region epoxide theory re-
mained in favour, and it was not until the
recent definition of the terminal ring
diol-epoxide as the probable cancer-
critical intermediate that it faded from
prominence (reviewed Brookes, 1977).
This illustrates the potential value of
isosteric studies in cancer research. The
thiophene derivative (V), or related ones,
could also prove useful when studying the
response of carcinogens such as benzo[a]-
pyrene in in vitro carcinogenicity assays.
It has been separately observed (Glatt et
al., 1975; Oesch et al., 1976; Ashby &
Styles, 1978) that the in vitro response
given by such carcinogens is dominated
by the K-region epoxide. Therefore, the
in vitro study of isosteres such as V
should enable the metabolic activation of
the cancer critical "bay-region" diol-
epoxide (Jerina and Daly, 1976) to be
explored in isolation. Such studies may
become important, because the mutagenic
response given by both benz-[a]pyrene
(Oesch, 1972) and 7,12-dimethyl-benz-
[a]anthracene (Brookes, 1977; Bigger et
al., 1978) in the Ames assay appear to
arise from the non-cancer-critical K-
region epoxides. Such considerations must
influence the acceptance of any suggested
correlation between in vitro mutagenic
potency and carcinogenic potency (Messel-
son & Russell, 1977).
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